Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer
NCT ID: NCT02189369
Last Updated: 2017-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2015-02-28
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
NCT02148393
Uterine Elastography: a Potential Predictor of Embryo Transfer Success
NCT05397912
Quantitative Identification of Implantation Receptivity by Single Cell Transcriptome Analysis
NCT03091023
The Accuracy of Endometrial Ultrasound to Predict Implantation
NCT03860636
Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF
NCT02793089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Day 3 embryo-Own-above cutoff
Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates
Day 3 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer
Day 5 embryo-Own-above cutoff
Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates
Day 5 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer
Day 3 embryo-Donor-above cutoff
Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates
Day 3 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer
Day 5 embryo-Donor- above cutoff
Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates
Day 5 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer
Day 3 embryo-Donor-lower cutoff
Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates
Day 3 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer
Day 5 embryo-Donor-lower cutoff
Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates
Day 5 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer
Day 3 embryo-own-lower cutoff
Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates
Day 3 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer
Day 5 embryo-own-lower cutoff
Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates
Day 5 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Day 3 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer
Day 5 embryo transfer
Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI: 20 - 30
* Normal ovarian response (7 - 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral Follicle Count)
* Elective embryo transfer
* Normal uterine cavity
* Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with donated oocytes.
Exclusion Criteria
* Patients with severe male factor ( ≥ 2\*106 espermatozoides/ml).
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Igenomix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Simon
Dr. Carlos Simón
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Simon, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Fundación IVI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación IVI
Valencia, Valencia, Spain
IVI Valencia
Valencia, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1311-FIVI-135-CS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.